One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Neurotrophic Keratopathy: Current Concepts, Management, and Emerging Treatments.
doi : 10.1097/ICO.0000000000004055
Volume 45(6) pgs. 673-805,e19-e26 June 2026
Keratoconus Profile in the Elderly: Prevalence and Clinical Indices.
Latin American Consensus on Ocular Lubricants and Dry Eye Disease (LUBOS): A Report on Severity Classification, Diagnosis, and Therapy.
Barriers and Facilitators to Cornea Subspecialty for Ophthalmology Residents.
Femtosecond Descemet Membrane Endothelial Keratoplasty for Failed Deep Anterior Lamellar Keratoplasty: A Case Series.
Wide-Field Contact Specular Microscopy Can Reliably and Repeatedly Image the Same Corneal Endothelial Location.
Influence of Graft Donor Age in Descemet Membrane Endothelial Keratoplasty.
Infectious Keratitis After Corneal Cross-Linking: A Retrospective Case Series.
Outcomes of Photorefractive Keratectomy in First-Degree Relatives of Patients With Keratoconus.
Acanthamoeba Keratitis Secondary Glaucoma Associated With Mature Cataract and a Fixed Dilated Pupil in a 40-Eye Series.
Comparative Outcomes and Immune Mechanisms in Murine Endothelial Versus Penetrating Keratoplasty.
Myeloid-Derived Suppressor Cells Enhance Wound Healing in a Murine Model of Corneal Injury.
Early Clinical Outcomes of Cultured Human Corneal Endothelial Cell Injection (Vyznova) for Bullous Keratopathy: Initial Clinical Experience.
Laser Photocoagulation for Ocular Surface Keratinization: A Minimally Invasive Modality of Treatment.
Endothelium-In Pull-Through Descemet Membrane Endothelial Keratoplasty for Bullous Keratopathy in Vitrectomized Eyes.
A Modified Long Corneal Tunnel Technique for Intracameral Injection in Cultured Human Corneal Endothelial Cell Therapy (Vyznova): A Preliminary Technical Report.
DescePrep Significantly Improves the Efficiency of High-Risk Diabetic Donor Descemet Membrane Endothelial Keratoplasty Processing.
Letter Regarding: "Acanthamoeba Keratitis: Analysis of Risk Factors, Diagnostic Modalities, and Clinical Outcomes at a Tertiary Referral Ophthalmic Unit" Arun K et al. Published in Cornea 7th Sept. 2025
Letter Regarding Host Factors Drive Outcomes After DMEK Regrafts: In Response To: "Characteristics and outcomes of Descemet membrane endothelial keratoplasty for treatment of failed endothelial keratoplasty".
Comment on "Characteristics and Outcomes of Descemet Membrane Endothelial Keratoplasty for Treatment of Failed Endothelial Keratoplasty".
Letter Regarding: Temporary Conjunctival Flap Plus Medical Treatment Versus Medical Treatment Only for High-Risk Fungal Keratitis: A Randomized Controlled Trial.
Spatial Phenotyping of Endothelial Injury to Inform Graft Suitability after Shipping.
Letter to Editor in Response to Acanthamoeba Keratitis: Analysis of Risk Factors, Diagnostic Modalities, and Clinical Outcomes at a Tertiary Referral Ophthalmic Unit.
Response to Reframing the Risk in DMEK Regrafts: Host Environment Over Regraft Count.
Reply to Comment on "Temporary Conjunctival Flap plus Medical Treatment versus Medical Treatment Only for High-Risk Fungal Keratitis: A Randomized Controlled Trial".
